54 Biggest Movers From Yesterday
Gainers
eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares jumped 111.8% to settle at $27.17 on Wednesday after jumping 50% on Tuesday.
30 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Kadmon Holdings, Inc. (NASDAQ: KDMN) shares jumped 72.6% to $9.15. Sanofi announced Wednesday it has agreed to acquire New York-based biopharma Kadmon in a $1.9 billion all-cash deal.
The Daily Biotech Pulse: MacroGenics’ Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA’s FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 7)
21 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Kadmon Holdings, Inc. (NASDAQ: KDMN) rose 75.7% to $9.31 in pre-market trading after France's Sanofi announced plans to buy the company in a $1.9 billion deal.
53 Biggest Movers From Friday
Gainers
Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform.
The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week
Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday weekend.
Cowen Sees 100% Upside For This Medical Device Firm
Cowen has raised Impel NeuroPharma Inc's (NASDAQ: IMPL) price target to $55 from $35, with an Outperform rating, after the FDA approved Trudhesa for the acute treatment of migraine.
The analyst sees more than 100% upside for the stock.
Mid-Morning Market Update: Markets Mostly Lower; US Economy Adds 235,000 Jobs In August
Following the market opening Friday, the Dow traded down 0.41% to 35,300.08 while the NASDAQ rose 0.02% to 15,334.73. The S&P also fell, dropping 0.25% to 4,525.66.
FDA Gives Nod To Nasal Spray Migraine Treatment From Impel NeuroPharma; Stock Jumps
The FDA has approved Impel NeuroPharma Inc’s (NASDAQ:IMPL) Trudhesa (dihydroergotamine mesylate) nasal spray for the acute treatment of migraine with or…